FDA.reportPublic FDA data

Sandostatin 30 MG Injection

RxCUI
898603
RxNorm name
Sandostatin 30 MG Injection
Display name
Sandostatin 30 MG Injection
Full name
Sandostatin 30 MG Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:22

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Sandostatin LAR DepotOCTREOTIDE ACETATENovartis Pharmaceuticals Corporationd0b7fe9e-7000-4b79-ba3b-291ce92c14f92025-12-22Warnings, Adverse reactionsExact identifier
rxcui: 898603

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
d0b7fe9e-7000-4b79-ba3b-291ce92c14f9SandoSTATIN LAR 30 MG Injection [PSN] · octreotide 30 MG Injection [Sandostatin] [SBD] · Sandostatin 30 MG Injection [SY]329These highlights do not include all the information needed to use SANDOSTATIN LAR DEPOT safely and effectively. See full prescribing information for SANDOSTATIN LAR DEPOT. SANDOSTATIN ® LAR DEPOT (octreotide acetate) for injectable suspension, for gluteal intramuscular use Initial U.S. Approval: 198820251222